Clinical Trials Directory

Trials / Completed

CompletedNCT03189303

Cup Position in THA With Standard Instruments

Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Standard Instrumentation and Technique

Status
Completed
Phase
Study type
Observational
Enrollment
183 (actual)
Sponsor
DePuy Orthopaedics · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Prospective, global, multicenter study to assess cup position in THA. After written informed consent has been obtained, study evaluations will be collected from the pre-op clinic visit, the operative visit (including discharge), and 6 and 12 weeks postoperatively.

Detailed description

This is a global, prospective, multi-center study with a planned analysis of a minimum of 176 Subjects. Up to 15 study sites will participate in this study. The primary and secondary endpoints are as follows: Primary endpoint: The primary endpoint is acetabular cup position success at 6 weeks postoperatively. Success is defined as cup inclination and version within 10 degrees of the plan. Secondary endpoints: 1. Inclination success (as defined for the primary endpoint) 2. Version success (as defined for the primary endpoint) 3. 90-day complication rates 4. Change from preoperative baseline for the Harris Hip Score 5. Radiographic Outcomes (based upon: AP Hip, AP Pelvis, and Modified Lauenstein Lateral) 6. Change from preoperative baseline for the EQ-5D-5L (health state, EQ-VAS, and index value, if applicable) 7. Change from 6 week baseline for the Forgotten Joint Score

Conditions

Interventions

TypeNameDescription
DEVICEPrimary Uncemented Total Hip ArthroplastyThe study devices are the Pinnacle Hip System acetabular cup with a Summit, Actis, or Corail femoral stem

Timeline

Start date
2017-09-07
Primary completion
2021-05-19
Completion
2021-12-14
First posted
2017-06-16
Last updated
2022-02-15

Locations

11 sites across 4 countries: United States, Italy, Netherlands, United Kingdom

Regulatory

Source: ClinicalTrials.gov record NCT03189303. Inclusion in this directory is not an endorsement.